|
|
|
Volumn 51, Issue 1, 1997, Pages 2-3
|
|
Statins and coronary artery disease--it's the clinical endpoints that count.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHOLESTEROL;
DRUG DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE;
HYPOCHOLESTEROLEMIC AGENT;
MEVINOLIN;
PRAVASTATIN;
SIMVASTATIN;
BLOOD;
CORONARY ARTERY DISEASE;
DRUG ANTAGONISM;
EDITORIAL;
HEART INFARCTION;
HUMAN;
MORTALITY;
ANTICHOLESTEREMIC AGENTS;
CHOLESTEROL;
CORONARY DISEASE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA SYNTHASE;
LOVASTATIN;
MYOCARDIAL INFARCTION;
PRAVASTATIN;
SIMVASTATIN;
|
|
EID: 0030629103
PISSN: 00070947
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (8)
|
|
References (0)
|
